REQUEST A DEMO
Total
USD $0.00
Search more companies

Unam Pharmaceutical (M) Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Unam Pharmaceutical (M) Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Unam Pharmaceutical (M) Sdn. Bhd. is based in Malaysia. The head office is in Petaling Jaya. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on December 20, 1965. In 2022, the company reported a net sales revenue increase of 2.12%. Its total assets decreased by 11.41% over the same period. The net profit margin of Unam Pharmaceutical (M) Sdn. Bhd. decreased by 2.65% in 2022.

Headquarters
Suite 803,Block F, Phileo Damansara 1, No.9,Jalan 16/11
Petaling Jaya; Selangor; Postal Code: 46350

Contact Details: Purchase the Unam Pharmaceutical (M) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Unam Pharmaceutical (M) Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Unam Pharmaceutical (M) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Unam Pharmaceutical (M) Sdn. Bhd. report to view the information.
Incorporation Date:
December 20, 1965
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Blue Sphere Singapore Pte. Ltd.
100%
Company Performance
Financial values in the chart are available after Unam Pharmaceutical (M) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
2.12%
Total operating revenue
2.12%
Operating profit (EBIT)
-26.53%
EBITDA
-26.4%
Net Profit (Loss) for the Period
-26.53%
Total assets
-11.41%
Total equity
17.38%
Operating Profit Margin (ROS)
-2.65%
Net Profit Margin
-2.65%
Return on Equity (ROE)
-8.84%
Quick Ratio
1.57%
Cash Ratio
1.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?